# To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne Vulgaris

> **NCT03427554** · EARLY_PHASE1 · COMPLETED · sponsor: **Sun Pharmaceutical Industries, Inc.** · enrollment: 455 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Tretinoin cream 0.1%
- **DRUG:** RETIN-A® Cream
- **DRUG:** Vehicle of the test product

## Key facts

- **NCT ID:** NCT03427554
- **Lead sponsor:** Sun Pharmaceutical Industries, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-21
- **Primary completion:** 2018-01-26
- **Final completion:** 2018-01-26
- **Target enrollment:** 455 (ACTUAL)
- **Last updated:** 2018-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03427554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03427554, "To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne Vulgaris". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03427554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*